Driehaus Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $12M | Buy |
|
|||||
|
2024
Q4 | $14M | Buy |
|
|||||
|
2024
Q3 | $8.16M | Sell |
|
|||||
|
2024
Q2 | $9.82M | Sell |
|
|||||
|
2024
Q1 | $9.87M | Sell |
|
|||||
|
2023
Q4 | $15.4M | Sell |
|
|||||
|
2023
Q3 | $21.8M | Buy |
|
|||||
|
2023
Q2 | $12M | Sell |
|
|||||
|
2023
Q1 | $19.5M | Sell |
|
|||||
|
2022
Q4 | $28.8M | Buy |
|
|||||
|
2022
Q3 | $23.6M | Buy |
|
|||||
|
2022
Q2 | $9.54M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $315K | Sell |
|
|||||
|
2020
Q1 | $604K | Sell |
|
|||||
|
2019
Q4 | $2.14M | Sell |
|
|||||
|
2019
Q3 | $2.84M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.2M | Buy |
|
|||||
|
2018
Q2 | $1.44M | Sell |
|
|||||
|
2018
Q1 | $1.36M | Buy |
|
|||||
|
2017
Q4 | $1.03M | Sell |
|
|||||
|
2017
Q3 | $876K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $892K | Sell |
|
|||||
|
2013
Q2 | $6.71M | Buy |
|